CHINASOFT INT'L (HKEX: 00354) has pioneered a new "AI + Energy" integration model based on its FDE system, securing a major contract for a hydropower smart operation large model project worth 44.155 million yuan with the Yalong River authority.
SUNSHINE PHARMA (HKEX: 06887) has entered into a partnership agreement with Shenzhen Sunshine Technology and Zhejiang Sunshine Health to jointly establish an investment fund.
MEDBOT-B (HKEX: 02252) announced that the global commercial installations of its Toumai surgical robot have surpassed 200 units, indicating a maturing global clinical ecosystem.
COSCO SHIP PORT (HKEX: 01199) has introduced COSCO SHIPPING (Hong Kong) as an investor to increase capital in the Abu Dhabi container yard station, reinforcing its hub strategy in the Middle East under the Belt and Road Initiative.
Jinyong Investment (HKEX: 01328) has led an investment to acquire approximately 5.19% of Grace Investment Machine Limited and has entered into a comprehensive strategic cooperation with the company.
CSPC Pharmaceutical Group (HKEX: 01093) has officially initiated a Phase III clinical study in China for SYS6010 in combination with Enlang Subai Monoclonal Antibody for the treatment of driver gene-negative non-small cell lung cancer.
Financial Performance Highlights
CHINA GAS HOLD (HKEX: 00384) reported revenue of approximately HKD 73.604 billion for the 2026 fiscal year. Its free cash flow reached HKD 4.838 billion, representing a year-on-year increase of 3.8%.
China Power International Development (HKEX: 02380) recorded total consolidated electricity sales of 10.7545 million MWh in May, marking a 4.55% increase compared to the same period last year.
Wing Yee International (HKEX: 01218) released its annual results, reporting an attributable loss of HKD 435 million, which narrowed by 39.34% year-on-year.
Pudatek Technology (HKEX: 00650) announced that its semiconductor equipment business revenue surged by 118.6% for the 2025 fiscal year, with an order backlog reaching HKD 209 million.
Cloudreams Technology (HKEX: 02131) published its 2024 annual results, showing a net loss attributable to owners of RMB 460 million, shifting from a profit to a loss compared to the previous year.